Edition:
United States

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

1.06USD
14 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
34,654
52-wk High
$5.00
52-wk Low
$0.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.189
Mar '18 0.00 -0.442
Dec 0.00 -0.377
FY 2017 Sep '17 0.00 -0.448
Jun '17 0.00 -0.489
Mar '17 0.00 -0.549
Dec 0.00 -0.444
FY 2016 Sep '16 0.00 -0.530
Jun '16 0.00 -0.746
Mar '16 0.00 -0.350
Dec 0.00 -0.532
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Sep-18 1 0.00 0.00 0.00 --
Earnings (per share)
Year Ending Sep-18 1 -1.57 -1.57 -1.57 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.45 30.88
P/E High - Last 5 Yrs. -- 41.60 46.69
P/E Low - Last 5 Yrs. -- 25.00 25.78
Beta -- 0.98 0.95
Price to Sales (TTM) -- 19.89 21.76
Price to Book (MRQ) 0.58 4.30 4.53
Price to Tangible Book (MRQ) 29.48 12.11 11.76
Price to Cash Flow (TTM) -- 21.70 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.68 1.60
Dividend Yield - 5 Year Avg -- 1.49 1.42
Dividend 5 Year Growth Rate -- -11.45 -8.76
Payout Ratio(TTM) -- 46.02 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.36 6.54
Sales (TTM) vs TTM 1 Yr. Ago -- 3.97 5.26
Sales - 5 Yr. Growth Rate -- 7.07 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago 61.28 22.48 22.50
EPS (TTM) vs TTM 1 Yr. Ago 27.59 -- --
EPS - 5 Yr. Growth Rate -- 6.71 7.64
Capital Spending - 5 Yr. Growth Rate -- 8.06 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.65 2.63
Current Ratio (MRQ) 1.29 3.71 3.68
LT Debt to Equity (MRQ) 0.00 7.50 9.53
Total Debt to Equity (MRQ) 0.80 10.94 13.39
Interest Coverage (TTM) -- 40.82 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.06 50.91
Gross Margin - 5 Yr. Avg. -- 52.20 52.22
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.43 16.27
Operating Margin (TTM) -- 8.35 -15.11
Operating Margin - 5 Yr. Avg. -- 14.50 11.89
Pre-Tax Margin (TTM) -- 8.99 -13.67
Pre-Tax Margin - 5 Yr. Avg. -- 14.91 12.22
Net Profit Margin (TTM) -- 5.44 -17.11
Net Profit Margin - 5 Yr. Avg. -- 11.12 8.44
Effective Tax Rate (TTM) -- 21.91 21.73
Effective Tax Rate - 5 Yr. Avg. -- 23.94 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 989,839,630 878,349,382
Net Income/Employee (TTM) -- 115,653,467 102,474,711
Receivable Turnover (TTM) -- 5.43 5.49
Inventory Turnover (TTM) -- 2.74 3.99
Asset Turnover (TTM) 0.00 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.10 11.53 11.06
Return on Assets - 5 Yr. Avg. -- 12.44 11.85
Return on Investment (TTM) -76.64 14.34 13.80
Return on Investment - 5 Yr. Avg. -- 15.95 15.17
Return on Equity (TTM) -76.64 15.85 15.29
Return on Equity - 5 Yr. Avg. -- 16.93 16.29
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 17.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Citius Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.58%
# of Holders: 14
Total Shares Held: 256,384
3 Mo. Net Change: -270,253
# New Positions: 5
# Closed Positions: 1
# Increased Positions: 8
# Reduced Positions: 2
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.